ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Business/CompaniesArticle

LifeVantage outlines turnaround plan, cites strong margins and dividend

CEO Terrence Moorehead and CFO Carl Aure detailed a three‑point strategy to revive the supplement maker, noting near‑80% gross margin, a $0.18 dividend and a debt‑free balance sheet.

HV
Helena Vásquez · Business Desk · 23 Sept 2026 · 18:47 · 2 min read
Share
LifeVantage outlines turnaround plan, cites strong margins and dividend

LifeVantage (LFVN) used the Water Tower Research Virtual Insights Conference on Sept. 23, 2026, to present a comprehensive turnaround agenda under its new chief executive, Terrence Moorehead, who has been in the role for a few weeks. Moorehead identified three priorities: strengthening the LifeVantage brand, delivering a more consumer‑focused product proposition, and boosting operational efficiency.

The company reported a gross margin that remains "nearly 80%" and an SG&A expense ratio that has risen to 32% of revenue. Management said $10 million of SG&A costs have been eliminated, representing roughly a 15% cut in that line item. EBITDA margins have slipped in fiscal 2026 as top‑line growth stalled and scale eroded over the prior 12‑18 months.

LifeVantage continues to pay an annual dividend of $0.18 per share, amounting to about $2.3 million and yielding 3.22%. Share repurchases have historically ranged between $2 million and $6 million a year, and the balance sheet is debt‑free. International operations contribute about 20% of total revenue.

Product-wise, the firm highlighted its Protandim line—Nrf2, Nrf1 and NAD—as clinically validated supplements that have not been marketed effectively to consumers. The newer MindBody GLP‑1 System, which saw rapid growth in fiscal 2025 as the only natural GLP‑1 offering in the U.S., experienced a sharp sales decline in fiscal 2026 due to heightened competition, price moderation and limited new customer acquisition.

LifeVantage operates an asset‑light, fully outsourced manufacturing model, primarily with U.S. contract manufacturers and a localized sourcing arrangement in Japan. The company is evaluating sourcing in Mexico to lower costs, improve pricing competitiveness and accelerate product launches.

Geographically, the focus will be on reinforcing the U.S. business before pursuing new markets. Japan is identified as the top Asia‑Pacific opportunity, while Mexico offers double‑digit growth potential in the supplement sector.

Internally, the firm introduced the concepts of Zero Overhead Growth (ZOG) and Negative Overhead Growth (NOG), aiming to leverage technology, automation and AI to increase sales‑force contact frequency from roughly twice a year to 12‑20 interactions via digital channels. Management emphasized "growing our way to success rather than cutting our way to success" as the guiding principle for the turnaround.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
HV
Written by
Helena Vásquez
Business Desk

Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.

More from Helena Vásquez →
ADVERTISEMENT
ADVERTISEMENT
LifeVantage outlines turnaround plan with strong margins and dividend · Finance Review Daily